Effect of quercetin on bone formation

Journal of Orthopaedic Research

Volumn 26, Issue 8, 2008, Pages 1061-1066

  Wong, Ricky W K ^a   Rabie, A Bakr M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone repair; Flavonol; Phytoestrogen; Quercetin

Indexed keywords

QUERCETIN; ANTIOXIDANT; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; BONE MATRIX; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMAGE ANALYSIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; ANIMAL; BONE DISEASE; BONE REGENERATION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; PATHOLOGY; SKULL;

ANIMALS; ANTIOXIDANTS; BONE DISEASES; BONE REGENERATION; COLLAGEN; DISEASE MODELS, ANIMAL; QUERCETIN; RABBITS; SKULL;

EID: 49149126753     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20638     Document Type: Article

References (34)

1. Lane JM, Tomin E, Bostrom MPG. 1999. Biosynthetic bone grafting. Clin Orthop 367S:S107-S117.
2. Younger EM, Chapman MW. 1989. Morbidity at bone graft donor sites. J Orthop Trauma 3:192-195.
3. Zins JE, Whitaker LA. 1983. Membranous versus endochondral bone: implications for craniofacial reconstruction. Plast Reconst Surg 72:778-784.
4. Strong DM, Friedlaender GE, Tomford WW, et al. 1996. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop 326:107-114.
5. Turner RT, Riggs BL, Spelsberg TC. 1994. Skeletal effects of estrogen. Endocr Rev 15:275-300.
6. Chow J, Tobias JH, Colston KW, et al. 1992. Estrogen maintains trabecular bone volume in rats not only by suppression of bone-resorption but also by stimulation of bone-formation. J Clin Invest 89:74-78.
7. Qu Q, Perala-Heape M, Kapanen A, et al. 1998. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22:201-209.
8. Takano-Yamamoto T, Rodan GA. 1990. Direct effects of 17-β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172-2176.
9. Qu Q, Harkonen PL, Monkkonen J, et al. 1999. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone 25:211-215.
10. Branca F. 2003. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 62:877-887.
11. Hathena SJ, Velasquez MT. 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201.
12. Duncan AM, Phipps WR, Kurzer MS. 2003. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 17:253-271.
13. Arts J, Kuiper GG, Janssen JM, et al. 1997. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070.
14. Kuiper GG, Lemmen JG, Carlsson B, et al. 1998. Interaction of estrogenic chemicals and phytoestrogens with receptor beta. Endocrinology 139:4252-4563.
15. Harris HA, Bapat AR, Gonder DS, et al. 2002. The ligand binding profiles of estrogen receptors alpha and beta are species dependent. Steroids 67:379-384.
16. Prouilleta C, Mazièreb JC, Mazièreb C, et al. 2004. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67:1307-1313.
17. Price KR, Rhodes MJC. 1997. Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J Sci Food Agric 74:331-339.
18. Hertog MG, Feskens EJ, Hollman PC, et al. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet 342:1007-1011.
19. Kanno S, Hirano S, Kayama F. 2004. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 196:137-145.
20. Wong RWK, Rabie ABM. 1999. A quantitative assessment of the healing of intramembranous and endochondral autogenous bone grafts. Eur J Orthod 21:119-126.
21. Wong RWK, Rabie ABM. 2003. Statin collagen grafts used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg 41:244-248.
22. Kim YJ, Bae YC, Suh KT, et al. 2006. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 72:1268-1278.
23. Rabie ABM, Lie KJ. 1996. Integration of endochondral bone grafts in the presence of demineralized bone matrix. Int J Oral Maxillofac Surg 25:311-318.
24. Rabie ABM, Wong RWK, Hägg U. 1999. Bone induction using autogenous bone mixed with demineralised bone matrices. Aust Orthod J 15:269-275.
25. Rabie ABM, Wong RWK, Hägg U. 2000. Composite autogenous bone and demineralised bone matrices used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg 38:565-570.
26. Wong RWK, Rabie ABM. 2005. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg 43: 46-50.
27. Nevins M, Kirker-Head C, Nevins M. 1996. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein - 2. Int J Periodont Rest Dent 16:9-19.
28. Li ST. 1996. Collagen as a delivery vehicle for bone morphogenetic protein (BMP). Trans Orthop Res Soc 21:647.
29. Boyne PJ, Marx RE, Nevins M. 1997. A feasibility study evaluating rhBMP - 2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodont Rest Dent 17:11-25.
30. Chin M, Ng T, Torn WK, et al. 2005. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg 5:778-789.
31. Bouxsein ML, Turek TJ, Blake CA. 2001. Recombinant human bone morphogenetic protein - 2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 83A: 1219-1230.
32. Chen X. 2004. The clinical observation of puerarin injection on unstable angina pectoris. Zhongyaocai 27:77-78.
33. Zhu XJ, Wei SQ. 2005. Protective effect of quercetin on ovariectomy-induced bone loss in rats. Chin J Osteoporos 11:504-508.
34. Chen X, Yin QP, Zuo Z, et al. 2005. Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 22:892-901.